Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bioventus (BVS) Non-Current Deferred Tax Liability (2020 - 2025)

Historic Non-Current Deferred Tax Liability for Bioventus (BVS) over the last 6 years, with Q3 2025 value amounting to $786000.0.

  • Bioventus' Non-Current Deferred Tax Liability changed N/A to $786000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $786000.0, marking a year-over-year change of. This contributed to the annual value of $564000.0 for FY2024, which is 7252.8% down from last year.
  • Latest data reveals that Bioventus reported Non-Current Deferred Tax Liability of $786000.0 as of Q3 2025.
  • Bioventus' Non-Current Deferred Tax Liability's 5-year high stood at $159.3 million during Q4 2022, with a 5-year trough of $351000.0 in Q2 2023.
  • For the 5-year period, Bioventus' Non-Current Deferred Tax Liability averaged around $41.0 million, with its median value being $29.2 million (2022).
  • Its Non-Current Deferred Tax Liability has fluctuated over the past 5 years, first surged by 110775.46% in 2021, then crashed by 9969.75% in 2023.
  • Over the past 5 years, Bioventus' Non-Current Deferred Tax Liability (Quarter) stood at $59.7 million in 2021, then plummeted by 50.98% to $29.2 million in 2022, then tumbled by 92.98% to $2.1 million in 2023, then tumbled by 72.53% to $564000.0 in 2024, then soared by 39.36% to $786000.0 in 2025.
  • Its last three reported values are $786000.0 in Q3 2025, $651000.0 for Q2 2025, and $607000.0 during Q1 2025.